miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity
Authors
Keywords
-
Journal
CELL DEATH AND DIFFERENTIATION
Volume 18, Issue 3, Pages 465-478
Publisher
Springer Nature
Online
2010-10-01
DOI
10.1038/cdd.2010.119
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer
- (2010) M İlie et al. BRITISH JOURNAL OF CANCER
- Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene
- (2010) F M Buffa et al. BRITISH JOURNAL OF CANCER
- miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer
- (2010) Antonis Giannakakis et al. CANCER BIOLOGY & THERAPY
- MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT
- (2010) Zhan Zhang et al. CELL CYCLE
- Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression
- (2010) Z Chen et al. ONCOGENE
- MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU
- (2010) Elena Favaro et al. PLoS One
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- MicroRNA-210 Controls Mitochondrial Metabolism during Hypoxia by Repressing the Iron-Sulfur Cluster Assembly Proteins ISCU1/2
- (2009) Stephen Y. Chan et al. Cell Metabolism
- MicroRNAs and Lung Cancer: New Oncogenes and Tumor Suppressors, New Prognostic Factors and Potential Therapeutic Targets
- (2009) Cecile Ortholan et al. CURRENT MEDICINAL CHEMISTRY
- Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival
- (2009) Thomas Greither et al. INTERNATIONAL JOURNAL OF CANCER
- An Integrated Approach for Experimental Target Identification of Hypoxia-induced miR-210
- (2009) Pasquale Fasanaro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation
- (2009) Xin Huang et al. MOLECULAR CELL
- Identification of Keratinocyte Growth Factor as a Target of microRNA-155 in Lung Fibroblasts: Implication in Epithelial-Mesenchymal Interactions
- (2009) Nicolas Pottier et al. PLoS One
- A microRNA component of the hypoxic response
- (2008) R Kulshreshtha et al. CELL DEATH AND DIFFERENTIATION
- hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer
- (2008) C. Camps et al. CLINICAL CANCER RESEARCH
- MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3
- (2008) Pasquale Fasanaro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Detecting microRNA binding and siRNA off-target effects from expression data
- (2008) Stijn van Dongen et al. NATURE METHODS
- Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer
- (2008) J. A. Foekens et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search